Prof. Martin Schuler joins the board of the Oncology in Internal Medicine Working Group (AIO) within the German Cancer Society
In November, Prof. Martin Schuler, Director of Internal Medicine (tumor research) and spokesman for the Essen/Düsseldorf partner location of the German Cancer Consortium (DKTK), was voted onto ...
Michael Baumann, new scientific director of the German Cancer Research Center, is the new spokesperson of DKTK
The DKTK steering committee has unanimously elected Prof. Michael Baumann, the new scientific director of the German Cancer Research Center (DKFZ), as the new spokesperson of DKTK as of November 1, ...
DKTK: Incentive for clinically relevant cancer research: Joint Funding Contest rewards outstanding methods of diagnosis and therapy
The enormous growth in knowledge in cancer research presents physicians and scientists with the challenge of ensuring that patients not only benefit from the latest insights and developments but also ...